Table 3.

Competing risks regression model for transition from CVC to AVF, graft (AVG), and either AVF or AVG stratified by the presence or absence of a maturing AVF/AVG at the time of initiating hemodialysis

Patient Characteristics	No Maturing Access in Place			Maturing Access in Place
	n=65,822			n=8372
	AVF	AVG	AVF or AVG	AVF	AVG	AVF or AVG
Race/ethnicity (reference: white)
Black	0.90	1.82	1.17	0.80	1.71	0.98
	[0.86 to 0.93]	[1.71 to 1.94]	[1.13 to 1.22]	[0.76 to 0.85]	[1.54 to 1.90]	[0.94 to 1.03]
Hispanic	1.28	1.06	1.24	0.96	1.04	0.96
	[1.22 to 1.36]	[0.97 to 1.17]	[1.18 to 1.30]	[0.89 to 1.04]	[0.88 to 1.22]	[0.90 to 1.03]
Other race	1.30	1.39	1.38	0.99	1.38	1.09
	[1.21 to 1.39]	[1.25 to 1.56]	[1.30 to 1.47]	[0.90 to 1.08]	[1.15 to 1.65]	[1.01 to 1.19]
Female sex (reference: male)	0.80	1.49	0.96	0.83	1.47	0.95
	[0.78 to 0.83]	[1.41 to 1.56]	[0.94 to 0.99]	[0.80 to 0.87]	[1.35 to 1.60]	[0.91 to 0.98]
Age category (reference: 66–70 yr)
Age 71–75	0.94	1.07	0.98	0.99	1.05	1.01
	[0.91 to 0.98]	[0.99 to 1.14]	[0.95 to 1.02]	[0.93 to 1.04]	[0.94 to 1.18]	[0.96 to 1.06]
Age 76–80	0.88	1.15	0.96	0.97	1.10	1.00
	[0.85 to 0.92]	[1.07 to 1.24]	[0.92 to 0.99]	[0.92 to 1.03]	[0.97 to 1.23]	[0.95 to 1.06]
Age 81+	0.75	1.13	0.85	0.88	1.22	0.97
	[0.72 to 0.78]	[1.06 to 1.21]	[0.82 to 0.88]	[0.83 to 0.94]	[1.09 to 1.38]	[0.92 to 1.02]
Received Pre-ESKD nephrology care (reference: no)	1.18	1.23	1.24	1.16	0.98	1.13
	[1.14 to 1.22]	[1.16 to 1.30]	[1.20 to 1.27]	[1.10 to 1.23]	[0.88 to 1.09]	[1.08 to 1.19]

Exponentiated coefficients; 95% CIs in brackets. Covariates included age, race/ethnicity, sex, body mass index, peripheral arterial disease, congestive heart failure, atherosclerotic heart disease, other cardiac disease, diabetes, creatinine, GFR, pre-ESKD nephrology care, functional status, hospitalization within the past year, institutionalization, income, US Renal Data System network, rurality, and Medicaid enrollment. Standardized hazard ratios and 95% CIs reported.